AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019
Dec 31, 2019
30583_dirs_2019-12-30_dc7835f3-c521-48a6-b9e8-4469f64f9eb9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-12-03
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-26 | Common Stock | M | 3000 | $21.51 | Acquired | 330530 | Direct |
| 2019-12-26 | Common Stock | S | 3000 | $86.43 | Disposed | 327530 | Direct |
| 2019-12-27 | Common Stock | M | 5000 | $21.51 | Acquired | 332530 | Direct |
| 2019-12-27 | Common Stock | S | 5000 | $86.16 | Disposed | 327530 | Direct |
| 2019-12-03 | Common Stock | G | 630 | — | Disposed | 180261 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-26 | Stock Option (Right to buy Common Stock) | $21.51 | M | 3000 | Disposed | 2020-05-11 | Common Stock (3000) | Direct |
| 2019-12-27 | Stock Option (Right to buy Common Stock) | $21.51 | M | 5000 | Disposed | 2020-05-11 | Common Stock (5000) | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on June 11, 2019.
F2: On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by increasing the total amount of securities beneficially owned by the reporting person by such 450 shares.
F3: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
F4: Trade made pursuant to a 10b5-1 plan executed on September 6, 2019.
F5: On December 3, 2019 the reporting person gifted 630 shares to a charitable organization.
F6: On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by decreasing the total amount of securities beneficially owned by the reporting person's trust by such 450 shares.
F7: Reflects the number of options outstanding after the transactions from this specific stock option grant.